Release 34 features the first ever release of Mouse Vega genes (chromosomes 1, 3, 4, 11 and 13) in Ensembl. See Vega Mouse for details of the annotated regions.
A new dynamic page, GeneRegulationView, displays all the regulatory factors for a given gene; it can be reached via the lefthand menu on a GeneView page where the gene has regulatory information available.
Read more...
"What's New" items from releases prior to the new website design have been imported into the database, and can now be accessed through a new dynamic page, NewsView.
Read more...
Click on a chromosome for a closer view
Ensembl Mouse is based on the NCBI m34 mouse assembly (freeze May 17, 2005, strain C57BL/6J).
The Mouse Genome Sequencing Consortium is a joint project between
The Whitehead Institute/MIT Center for Genome Research,
The Washington University Genome Sequencing Center,
The Wellcome Trust Sanger Institute
and EMBL - EBI to provide the Mouse genome sequence to the world.
We work closely with other Mouse groups to provide an integrated resource (see below for credits).
This site provides a full Ensembl gene build for the above assembly. There are some major changes in the assembly; for more details see the NCBI build statistics . The un-assembled pieces of the Y-chromosome will probably be re-integrated in the upcoming build 35.
Modifications to the systems have further improved the gene set. More than 93% of known genes from build m33 retain the same Ensembl gene ids in this release. Of novel genes only 55% of identifiers are retained, half of those lost were pseudogenes.
| Assembly: | NCBI m34, May 2005 |
| Genebuild: | Ensembl, July 2005 |
| Database version: | 34.34b |
| Gene predictions (incl. 1383 pseudogenes): | 26,996 |
| Genscan gene predictions: | 81,307 |
| Gene exons: | 245,205 |
| Gene transcripts: | 37,854 |
| Base Pairs: | 2,267,775,209 |
| Golden Path Length: | 2,604,449,128 |
| Most common InterPro domains: | Top 40 Top 500 |
© 2008 WTSI / EBI. Ensembl is available to download for public use - please see the code licence for details.